Clinical Trials Directory

Trials / Completed

CompletedNCT01721395

Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Penn State University · Academic / Other
Sex
All
Age
2 Months – 48 Months
Healthy volunteers
Not accepted

Summary

Cough is a frequent symptom in children and infants and is one of the most common reasons parents visit a healthcare provider for their child. The US Food and Drug Administration has issued a warning that over-the-counter cough and cold medicines including antihistamines, decongestants, anti-tussives, and expectorants should not be administered to children younger than 2 years of age due not only to lack of proven efficacy, but also because of important safety concerns. Honey, another method of soothing cough cannot be used in children \<1 year due to concerns for infantile botulism. A preparation from agave syrup has been created to address the need for an infant cough syrup. Although no studies have formally evaluated the use of agave nectar for nocturnal cough associated with Upper Respiratory Infections, the demulcent effect and sweet taste of agave nectar may provide some relief from cough in children.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAgave Syrup

Timeline

Start date
2013-01-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2012-11-05
Last updated
2015-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01721395. Inclusion in this directory is not an endorsement.

Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and (NCT01721395) · Clinical Trials Directory